STOCK TITAN

[SCHEDULE 13D/A] MEI Pharma, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Amendment No. 9 to Schedule 13D – MEIP (filed 24-Jul-25)

The Cable Car/Anson activist coalition discloses that MEI Pharma’s 17-Jul-25 private placement diluted its combined stake below the 5 % reporting threshold. The group now owns 1,093,188 shares, or 3.7 % of the 29,879,755 shares outstanding, and therefore ceases to act as a Section 13(d) group. Individual holdings: Funicular Funds/Cable Car/J. Ma-Weaver 35,300 sh (0.1 %); Anson Investments Master 841,674 sh (2.8 %); Anson East Master 214,304 sh (0.7 %); Anson Opportunities Master 37,210 sh (0.1 %).

Because the “Minimum Ownership Amount” in the 2023 Cooperation Agreement was no longer satisfied, Anson-appointed director Taheer Datoo resigned effective 22-Jul-25. On the same date all parties executed mutual terminations of both the Cooperation Agreement and the Group Agreement. Each fund acquired its position for cash (≈ US $12.9 m aggregate) without margin financing and now disclaims beneficial ownership of shares it does not directly hold.

Implication: activist governance pressure and mandatory 13D amendments end, reducing the likelihood of further board or strategic agitation from these investors.

Emendamento n. 9 al Schedule 13D – MEIP (depositato il 24-lug-25)

La coalizione attivista Cable Car/Anson comunica che il collocamento privato di MEI Pharma del 17-lug-25 ha diluito la loro partecipazione combinata al di sotto della soglia di segnalazione del 5%. Il gruppo detiene ora 1.093.188 azioni, pari al 3,7% delle 29.879.755 azioni in circolazione, cessando quindi di agire come gruppo ai sensi della Sezione 13(d). Partecipazioni individuali: Funicular Funds/Cable Car/J. Ma-Weaver 35.300 azioni (0,1%); Anson Investments Master 841.674 azioni (2,8%); Anson East Master 214.304 azioni (0,7%); Anson Opportunities Master 37.210 azioni (0,1%).

Poiché il “Minimum Ownership Amount” previsto nell’Accordo di Cooperazione 2023 non era più soddisfatto, il direttore nominato da Anson, Taheer Datoo, si è dimesso con effetto dal 22-lug-25. Nella stessa data tutte le parti hanno firmato la risoluzione reciproca sia dell’Accordo di Cooperazione che dell’Accordo di Gruppo. Ogni fondo ha acquisito la propria posizione in contanti (circa 12,9 milioni di dollari USA complessivi) senza finanziamento a margine e ora nega la titolarità effettiva delle azioni che non detiene direttamente.

Implicazione: termina la pressione attivista sulla governance e gli emendamenti obbligatori 13D, riducendo la probabilità di ulteriori agitazioni strategiche o board da parte di questi investitori.

Enmienda No. 9 al Schedule 13D – MEIP (presentada el 24-jul-25)

La coalición activista Cable Car/Anson revela que la colocación privada de MEI Pharma del 17-jul-25 diluyó su participación combinada por debajo del umbral de reporte del 5%. El grupo ahora posee 1,093,188 acciones, o el 3.7% de las 29,879,755 acciones en circulación, por lo que deja de actuar como grupo según la Sección 13(d). Participaciones individuales: Funicular Funds/Cable Car/J. Ma-Weaver 35,300 acciones (0.1%); Anson Investments Master 841,674 acciones (2.8%); Anson East Master 214,304 acciones (0.7%); Anson Opportunities Master 37,210 acciones (0.1%).

Dado que el “Monto Mínimo de Propiedad” en el Acuerdo de Cooperación 2023 ya no se cumplía, el director designado por Anson, Taheer Datoo renunció con efecto a partir del 22-jul-25. En la misma fecha, todas las partes firmaron la terminación mutua tanto del Acuerdo de Cooperación como del Acuerdo de Grupo. Cada fondo adquirió su posición en efectivo (≈ 12.9 millones de dólares estadounidenses en total) sin financiamiento con margen y ahora niega la propiedad beneficiosa de acciones que no posee directamente.

Implicación: finaliza la presión activista sobre la gobernanza y las enmiendas obligatorias 13D, reduciendo la probabilidad de nuevas agitaciones en la junta o estratégicas por parte de estos inversores.

Schedule 13D 수정안 9호 – MEIP (2025년 7월 24일 제출)

Cable Car/Anson 행동주의 연합은 MEI Pharma가 2025년 7월 17일에 실시한 사모 배정으로 인해 합산 지분이 5% 보고 기준선 아래로 희석되었음을 공개했습니다. 그룹은 현재 1,093,188주, 즉 발행 주식 총 29,879,755주의 3.7%를 보유하고 있어 13(d)조 그룹으로서의 활동을 중단합니다. 개별 보유 현황: Funicular Funds/Cable Car/J. Ma-Weaver 35,300주 (0.1%); Anson Investments Master 841,674주 (2.8%); Anson East Master 214,304주 (0.7%); Anson Opportunities Master 37,210주 (0.1%).

2023년 협력 계약서의 “최소 보유량” 조건이 더 이상 충족되지 않아 Anson이 지명한 이사 Taheer Datoo가 2025년 7월 22일부로 사임했습니다. 같은 날 모든 당사자는 협력 계약과 그룹 계약을 상호 해지하는 데 동의했습니다. 각 펀드는 현금(총 약 1,290만 달러 상당)으로 지분을 취득했으며 마진 금융 없이 직접 보유하지 않은 주식에 대한 실질적 소유권을 부인합니다.

의미: 행동주의 거버넌스 압력과 의무 13D 수정이 종료되어 이들 투자자로 인한 추가 이사회 또는 전략적 압박 가능성이 줄어듭니다.

Amendement n°9 au Schedule 13D – MEIP (déposé le 24-juil-25)

La coalition activiste Cable Car/Anson révèle que le placement privé de MEI Pharma du 17-juil-25 a dilué leur participation combinée en dessous du seuil de déclaration de 5 %. Le groupe détient désormais 1 093 188 actions, soit 3,7 % des 29 879 755 actions en circulation, et cesse donc d’agir en tant que groupe selon la Section 13(d). Participations individuelles : Funicular Funds/Cable Car/J. Ma-Weaver 35 300 actions (0,1 %) ; Anson Investments Master 841 674 actions (2,8 %) ; Anson East Master 214 304 actions (0,7 %) ; Anson Opportunities Master 37 210 actions (0,1 %).

Étant donné que le « Montant minimum de détention » dans l’Accord de Coopération 2023 n’était plus respecté, le directeur nommé par Anson, Taheer Datoo, a démissionné avec effet au 22-juil-25. À la même date, toutes les parties ont signé la résiliation mutuelle de l’Accord de Coopération ainsi que de l’Accord de Groupe. Chaque fonds a acquis sa position en numéraire (≈ 12,9 millions de dollars US au total) sans financement sur marge et renonce désormais à la propriété bénéficiaire des actions qu’il ne détient pas directement.

Implication : la pression activiste sur la gouvernance et les amendements obligatoires 13D prennent fin, réduisant la probabilité de nouvelles agitations au conseil ou stratégiques de la part de ces investisseurs.

Änderung Nr. 9 zu Schedule 13D – MEIP (eingereicht am 24. Juli 2025)

Die Aktivisten-Koalition Cable Car/Anson gibt bekannt, dass die Privatplatzierung von MEI Pharma am 17. Juli 2025 ihren kombinierten Anteil unter die Meldegrenze von 5 % verwässert hat. Die Gruppe hält nun 1.093.188 Aktien, bzw. 3,7 % der 29.879.755 ausstehenden Aktien und handelt somit nicht mehr als Gruppe gemäß Abschnitt 13(d). Einzelbeteiligungen: Funicular Funds/Cable Car/J. Ma-Weaver 35.300 Aktien (0,1 %); Anson Investments Master 841.674 Aktien (2,8 %); Anson East Master 214.304 Aktien (0,7 %); Anson Opportunities Master 37.210 Aktien (0,1 %).

Da der „Mindestbesitzbetrag“ im Kooperationsvertrag 2023 nicht mehr erfüllt war, trat der von Anson ernannte Direktor Taheer Datoo zum 22. Juli 2025 zurück. Am selben Tag einigten sich alle Parteien auf die gegenseitige Aufhebung sowohl des Kooperationsvertrags als auch des Gruppenvertrags. Jeder Fonds erwarb seine Position bar (ca. 12,9 Mio. USD insgesamt) ohne Margin-Finanzierung und bestreitet nun das wirtschaftliche Eigentum an Aktien, die er nicht direkt hält.

Folgerung: Der aktivistische Governance-Druck und die verpflichtenden 13D-Änderungen enden, was die Wahrscheinlichkeit weiterer Vorstands- oder strategischer Unruhen durch diese Investoren verringert.

Positive
  • Governance clarity: Termination of activist agreements removes uncertainty around future proxy contests.
  • Issuer cash infusion: Private placement closed 22-Jul-25, providing new capital (exact amount not disclosed here).
Negative
  • Activist catalyst removed: Combined stake drops to 3.7 %, ending board representation and reducing strategic pressure.
  • Dilution: Private placement increased outstanding shares to 29.88 m, diluting existing holders.
  • Lower transparency: Falling below 5 % means fewer mandatory disclosures going forward.

Insights

TL;DR – Activist group exits: stake now 3.7 %, board seat lost, pressure on MEIP subsides.

The Cable Car/Anson bloc has effectively stepped off the field. Falling under 5 % eliminates costly 13D compliance and strips the investors of rights embedded in the 2023 Cooperation Agreement—including their board designee. For shareholders who viewed the group as a catalyst for strategic alternatives or M&A, this is a setback. The modest residual stake (≈US $1.1 m at $1 share price) is unlikely to finance another campaign. The private placement both diluted their ownership and injected new capital into MEIP, shifting bargaining power back to management.

TL;DR – Governance normalises; activist oversight removed; impact depends on faith in current board.

The mutual termination of the Cooperation and Group Agreements restores a standard governance structure. Investors lose an independent monitor but also avoid potential distraction from prolonged proxy activity. Whether this is neutral or negative hinges on confidence in MEIP’s strategic plan; the filing itself carries no direct financial impact but signals diminished external accountability.

Emendamento n. 9 al Schedule 13D – MEIP (depositato il 24-lug-25)

La coalizione attivista Cable Car/Anson comunica che il collocamento privato di MEI Pharma del 17-lug-25 ha diluito la loro partecipazione combinata al di sotto della soglia di segnalazione del 5%. Il gruppo detiene ora 1.093.188 azioni, pari al 3,7% delle 29.879.755 azioni in circolazione, cessando quindi di agire come gruppo ai sensi della Sezione 13(d). Partecipazioni individuali: Funicular Funds/Cable Car/J. Ma-Weaver 35.300 azioni (0,1%); Anson Investments Master 841.674 azioni (2,8%); Anson East Master 214.304 azioni (0,7%); Anson Opportunities Master 37.210 azioni (0,1%).

Poiché il “Minimum Ownership Amount” previsto nell’Accordo di Cooperazione 2023 non era più soddisfatto, il direttore nominato da Anson, Taheer Datoo, si è dimesso con effetto dal 22-lug-25. Nella stessa data tutte le parti hanno firmato la risoluzione reciproca sia dell’Accordo di Cooperazione che dell’Accordo di Gruppo. Ogni fondo ha acquisito la propria posizione in contanti (circa 12,9 milioni di dollari USA complessivi) senza finanziamento a margine e ora nega la titolarità effettiva delle azioni che non detiene direttamente.

Implicazione: termina la pressione attivista sulla governance e gli emendamenti obbligatori 13D, riducendo la probabilità di ulteriori agitazioni strategiche o board da parte di questi investitori.

Enmienda No. 9 al Schedule 13D – MEIP (presentada el 24-jul-25)

La coalición activista Cable Car/Anson revela que la colocación privada de MEI Pharma del 17-jul-25 diluyó su participación combinada por debajo del umbral de reporte del 5%. El grupo ahora posee 1,093,188 acciones, o el 3.7% de las 29,879,755 acciones en circulación, por lo que deja de actuar como grupo según la Sección 13(d). Participaciones individuales: Funicular Funds/Cable Car/J. Ma-Weaver 35,300 acciones (0.1%); Anson Investments Master 841,674 acciones (2.8%); Anson East Master 214,304 acciones (0.7%); Anson Opportunities Master 37,210 acciones (0.1%).

Dado que el “Monto Mínimo de Propiedad” en el Acuerdo de Cooperación 2023 ya no se cumplía, el director designado por Anson, Taheer Datoo renunció con efecto a partir del 22-jul-25. En la misma fecha, todas las partes firmaron la terminación mutua tanto del Acuerdo de Cooperación como del Acuerdo de Grupo. Cada fondo adquirió su posición en efectivo (≈ 12.9 millones de dólares estadounidenses en total) sin financiamiento con margen y ahora niega la propiedad beneficiosa de acciones que no posee directamente.

Implicación: finaliza la presión activista sobre la gobernanza y las enmiendas obligatorias 13D, reduciendo la probabilidad de nuevas agitaciones en la junta o estratégicas por parte de estos inversores.

Schedule 13D 수정안 9호 – MEIP (2025년 7월 24일 제출)

Cable Car/Anson 행동주의 연합은 MEI Pharma가 2025년 7월 17일에 실시한 사모 배정으로 인해 합산 지분이 5% 보고 기준선 아래로 희석되었음을 공개했습니다. 그룹은 현재 1,093,188주, 즉 발행 주식 총 29,879,755주의 3.7%를 보유하고 있어 13(d)조 그룹으로서의 활동을 중단합니다. 개별 보유 현황: Funicular Funds/Cable Car/J. Ma-Weaver 35,300주 (0.1%); Anson Investments Master 841,674주 (2.8%); Anson East Master 214,304주 (0.7%); Anson Opportunities Master 37,210주 (0.1%).

2023년 협력 계약서의 “최소 보유량” 조건이 더 이상 충족되지 않아 Anson이 지명한 이사 Taheer Datoo가 2025년 7월 22일부로 사임했습니다. 같은 날 모든 당사자는 협력 계약과 그룹 계약을 상호 해지하는 데 동의했습니다. 각 펀드는 현금(총 약 1,290만 달러 상당)으로 지분을 취득했으며 마진 금융 없이 직접 보유하지 않은 주식에 대한 실질적 소유권을 부인합니다.

의미: 행동주의 거버넌스 압력과 의무 13D 수정이 종료되어 이들 투자자로 인한 추가 이사회 또는 전략적 압박 가능성이 줄어듭니다.

Amendement n°9 au Schedule 13D – MEIP (déposé le 24-juil-25)

La coalition activiste Cable Car/Anson révèle que le placement privé de MEI Pharma du 17-juil-25 a dilué leur participation combinée en dessous du seuil de déclaration de 5 %. Le groupe détient désormais 1 093 188 actions, soit 3,7 % des 29 879 755 actions en circulation, et cesse donc d’agir en tant que groupe selon la Section 13(d). Participations individuelles : Funicular Funds/Cable Car/J. Ma-Weaver 35 300 actions (0,1 %) ; Anson Investments Master 841 674 actions (2,8 %) ; Anson East Master 214 304 actions (0,7 %) ; Anson Opportunities Master 37 210 actions (0,1 %).

Étant donné que le « Montant minimum de détention » dans l’Accord de Coopération 2023 n’était plus respecté, le directeur nommé par Anson, Taheer Datoo, a démissionné avec effet au 22-juil-25. À la même date, toutes les parties ont signé la résiliation mutuelle de l’Accord de Coopération ainsi que de l’Accord de Groupe. Chaque fonds a acquis sa position en numéraire (≈ 12,9 millions de dollars US au total) sans financement sur marge et renonce désormais à la propriété bénéficiaire des actions qu’il ne détient pas directement.

Implication : la pression activiste sur la gouvernance et les amendements obligatoires 13D prennent fin, réduisant la probabilité de nouvelles agitations au conseil ou stratégiques de la part de ces investisseurs.

Änderung Nr. 9 zu Schedule 13D – MEIP (eingereicht am 24. Juli 2025)

Die Aktivisten-Koalition Cable Car/Anson gibt bekannt, dass die Privatplatzierung von MEI Pharma am 17. Juli 2025 ihren kombinierten Anteil unter die Meldegrenze von 5 % verwässert hat. Die Gruppe hält nun 1.093.188 Aktien, bzw. 3,7 % der 29.879.755 ausstehenden Aktien und handelt somit nicht mehr als Gruppe gemäß Abschnitt 13(d). Einzelbeteiligungen: Funicular Funds/Cable Car/J. Ma-Weaver 35.300 Aktien (0,1 %); Anson Investments Master 841.674 Aktien (2,8 %); Anson East Master 214.304 Aktien (0,7 %); Anson Opportunities Master 37.210 Aktien (0,1 %).

Da der „Mindestbesitzbetrag“ im Kooperationsvertrag 2023 nicht mehr erfüllt war, trat der von Anson ernannte Direktor Taheer Datoo zum 22. Juli 2025 zurück. Am selben Tag einigten sich alle Parteien auf die gegenseitige Aufhebung sowohl des Kooperationsvertrags als auch des Gruppenvertrags. Jeder Fonds erwarb seine Position bar (ca. 12,9 Mio. USD insgesamt) ohne Margin-Finanzierung und bestreitet nun das wirtschaftliche Eigentum an Aktien, die er nicht direkt hält.

Folgerung: Der aktivistische Governance-Druck und die verpflichtenden 13D-Änderungen enden, was die Wahrscheinlichkeit weiterer Vorstands- oder strategischer Unruhen durch diese Investoren verringert.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
Formerly known as Cable Car Capital LLC


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Funicular Funds, LP
Signature:/s/ Jacob Ma-Weaver
Name/Title:Jacob Ma-Weaver, Managing Member
Date:07/24/2025
Cable Car Capital, LP
Signature:/s/ Jacob Ma-Weaver
Name/Title:Jacob Ma-Weaver, Managing Member
Date:07/24/2025
Ma-Weaver Jacob
Signature:/s/ Jacob Ma-Weaver
Name/Title:Jacob Ma-Weaver
Date:07/24/2025
Anson Investments Master Fund LP
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director of AIMF GP LLC, its general partner
Date:11/01/2023
AIMF GP LLC
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director
Date:07/24/2025
Anson East Master Fund LP
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director of AEMF GP LLC, its general partner
Date:07/24/2025
AEMF GP LLC
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director
Date:07/24/2025
Anson Opportunities Master Fund LP
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director of AOMF GP, LLC, its general partner
Date:07/24/2025
AOMF GP, LLC
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Director
Date:07/24/2025
Anson Funds Management LP
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Manager of Anson Management GP LLC, its general partner
Date:07/24/2025
Anson Management GP LLC
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Manager
Date:07/24/2025
Tony Moore
Signature:/s/ Tony Moore
Name/Title:Tony Moore
Date:07/24/2025
Anson Advisors Inc.
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo, Director
Date:07/24/2025
Amin Nathoo
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo
Date:07/24/2025
Moez Kassam
Signature:/s/ Moez Kassam
Name/Title:Moez Kassam
Date:07/24/2025

FAQ

Why did Cable Car and Anson Funds file Amendment No. 9 for MEIP?

Their collective ownership fell below 5 % after MEIP’s 22-Jul-25 private placement, requiring an update and ending their Schedule 13D group status.

How much of MEI Pharma (MEIP) do the reporting persons now own?

They report 1,093,188 shares, or 3.7 % of the 29,879,755 shares outstanding as of 22-Jul-25.

Does the activist group still have a board seat at MEIP?

No. Director Taheer Datoo resigned on 22-Jul-25 because the group no longer meets the minimum ownership required for board representation.

What agreements were terminated on 22-Jul-25?

Both the Cooperation Agreement with MEIP and the internal Group Agreement among the investors were mutually terminated.

Will future 13D filings be required from these investors?

Not unless any of them again exceed the 5 % threshold; each filer now disclaims group status and owns below that level.
Mei Pharma Inc

NASDAQ:MEIP

MEIP Rankings

MEIP Latest News

MEIP Latest SEC Filings

MEIP Stock Data

41.31M
6.58M
1.31%
40.69%
0.09%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO